Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a post hoc analysis from a phase 3 migraine prevention study.

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

http://www.ncbi.nlm.nih.gov/pubmed/42327799

Christian Lampl; Dawn C Buse; Grazia Dell'Agnello; Janet H Ford; Lars Viktrup; Richard B Lipton; Sarah Lipsius

Jun 23, 2026